Developing a modern vaccine that is able to duplicate the protective immunity observered after immunization with irradiated P. falciparum (Pf) sporozoites requires identification of antigenic Pf proteins. The identification of Pf Liver Stage Antigen-3 and its ability to protect chimpanzees against sporozoite challenge suggests we are headed in the right direction (pages 1258–1263).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Daubersies, P. et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with a conserved pre-erythrocyte antigen, LSA-3. Nature Med. 6, 1258–1263 (2000).
Nussenzweig et al. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216, 160–162 (1967).
Clyde, D. F. et al. Immunization of man against sporozoite-induced falciparum malaria. Am.J.Med.Sci. 266, 169– 177 (1973).
Rieckmann, K. H. et al. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull.World Health Organ. 57, 261–265 ( 1979).
Doolan, D. L. & Hoffman, S.L. The complexity of protective immunity against liver-stage malaria. J Immunol. 165, 1453–1462 (2000).
Hoffman, S.L. et al. Attacking the infected hepatocyte. in Malaria Vaccine Development: A Multi-Immune Response Approach. (ed. Hoffman, S. L. Washington, DC) 35–75 (ASM Press, Bilthoven, The Netherlands, 1996).
Stoute, J. A. et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336, 86–91 (1997).
Aidoo, M. et al. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect. Immun. 68, 227–232 ( 2000).
Stoute, J. A. et al. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J. Infect. Dis. 178 , 1139–1144 (1998).
Lalvani, A. et al. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J. Infect. Dis. 180, 1656 –1664 (1999).
Le, T. P. et al. Intramuscular administration of a malaria DNA vaccine is safe, well-tolerated and induces CTL, but not detectable antibodies, in healthy human volunteers. Vaccine 18, 1893– 1901 (2000).
Wang, R. et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476 –480 (1998).
Hoffman, S. L. & Doolan, D. L. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization? in Development and Clinical Progress of DNA Vaccines (eds. Brown, F., Cichutek, R.& Robertson, J.) 104, 121–132 (Karger Publishers, Basel, 2000).
Gilbert, S. C. et al. A protein particle vaccine containing multiple malaria epitopes . Nature Biotechnol. 15,1280– 1284 (1997).
Gardner, M. J. et al. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science 282, 1126– 1132 (1998).
Hoffman, S. L. et al. From genomics to vaccines: malaria as a model system. Nature Med. 4, 1351–1353 (1998).
Miller, L.H. & Hoffman, S.L. Research toward vaccines against malaria. Nature Med. 4, 520– 524. (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffman, S., Doolan, D. Malaria vaccines–targeting infected hepatocytes. Nat Med 6, 1218–1219 (2000). https://doi.org/10.1038/81315
Issue Date:
DOI: https://doi.org/10.1038/81315
This article is cited by
-
In vitro production of infectious Plasmodium falciparum sporozoites
Nature (2022)
-
Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization
Malaria Journal (2007)
-
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites
Nature (2006)
-
Genetic vaccination approaches against malaria based on the circumsporozoite protein
Wiener klinische Wochenschrift (2006)
-
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
Nature (2005)